Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ENvue Medical (FEED) Cost of Revenue (2017 - 2025)

Historic Cost of Revenue for ENvue Medical (FEED) over the last 11 years, with Q3 2025 value amounting to $812000.0.

  • ENvue Medical's Cost of Revenue rose 23415.64% to $812000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 10909.09%. This contributed to the annual value of $1.0 million for FY2024, which is 2152.78% up from last year.
  • Latest data reveals that ENvue Medical reported Cost of Revenue of $812000.0 as of Q3 2025, which was up 23415.64% from $717000.0 recorded in Q2 2025.
  • Over the past 5 years, ENvue Medical's Cost of Revenue peaked at $812000.0 during Q3 2025, and registered a low of $161000.0 during Q4 2024.
  • Over the past 5 years, ENvue Medical's median Cost of Revenue value was $249000.0 (recorded in 2021), while the average stood at $325842.1.
  • As far as peak fluctuations go, ENvue Medical's Cost of Revenue tumbled by 3247.59% in 2022, and later surged by 23415.64% in 2025.
  • ENvue Medical's Cost of Revenue (Quarter) stood at $249000.0 in 2021, then dropped by 17.67% to $205000.0 in 2022, then grew by 13.66% to $233000.0 in 2023, then crashed by 30.9% to $161000.0 in 2024, then skyrocketed by 404.35% to $812000.0 in 2025.
  • Its Cost of Revenue stands at $812000.0 for Q3 2025, versus $717000.0 for Q2 2025 and $656000.0 for Q1 2025.